Endoscopic ultrasound (EUS)-guided pancreatic anti-tumoral therapy Jan. 05, 2021 Overview Show transcript Overview Michael J. Levy, M.D., a gastroenterologist at Mayo Clinic's campus in Rochester, Minnesota, discusses the use of EUS-guided pancreatic antitumoral therapy for the treatment of pancreatic masses. Dr. Levy addresses the safety, status, efficacy, and potential advantages and disadvantages associated with options available for local pancreatic ablation, including chemotherapy, alcohol injection and radiofrequency ablation. Share Doximity Facebook LinkedIn Twitter Print details Receive Mayo Clinic news in your inbox. Sign up Related ContentArticleDevelopment of new surgical procedures and predictors of outcome for patients with advanced pancreatic cancer VID-20506258 Medical Professionals Endoscopic ultrasound (EUS)-guided pancreatic anti-tumoral therapy